ENBIO Co., Ltd. (KOSDAQ:352940)
South Korea · Delayed Price · Currency is KRW 2,135.00
0.00 (0.00%)
At close: Feb 6, 2026
ENBIO Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 31,457 | 35,654 | 34,024 | 34,240 | 33,466 | 34,563 |
Other Revenue | - | -0 | -0 | - | - | - |
| 31,457 | 35,654 | 34,024 | 34,240 | 33,466 | 34,563 | |
Revenue Growth (YoY) | -10.22% | 4.79% | -0.63% | 2.31% | -3.17% | 2.45% |
Cost of Revenue | 22,195 | 24,081 | 26,970 | 27,898 | 22,713 | 20,231 |
Gross Profit | 9,262 | 11,573 | 7,055 | 6,342 | 10,753 | 14,332 |
Selling, General & Admin | 8,428 | 8,864 | 9,052 | 8,859 | 7,562 | 6,777 |
Research & Development | 660.76 | 660.76 | 578.48 | 523.54 | 387.91 | 469.14 |
Amortization of Goodwill & Intangibles | 16.16 | 16.16 | 17.23 | 1,064 | 1,123 | 1,042 |
Other Operating Expenses | 55.73 | 55.73 | 44.43 | 46.41 | 45.36 | 45.2 |
Operating Expenses | 9,821 | 10,194 | 10,408 | 11,119 | 9,631 | 10,237 |
Operating Income | -559.16 | 1,378 | -3,354 | -4,777 | 1,122 | 4,096 |
Interest Expense | -651.99 | -651.99 | -2,449 | -2,104 | -818.65 | -801.02 |
Interest & Investment Income | 79.04 | 86.74 | 347.08 | 256.72 | 96.61 | 36.2 |
Currency Exchange Gain (Loss) | -416.21 | -416.21 | -275.74 | - | -169.27 | 21.35 |
Other Non Operating Income (Expenses) | 826.26 | 90.88 | 380.31 | 2,793 | 6,158 | -8,113 |
EBT Excluding Unusual Items | -722.07 | 487.55 | -5,351 | -3,832 | 6,389 | -4,761 |
Gain (Loss) on Sale of Investments | 271.47 | 271.47 | 1.67 | - | - | - |
Gain (Loss) on Sale of Assets | 419.04 | 419.04 | 25.32 | - | 141.07 | 14.95 |
Asset Writedown | -293.42 | -293.42 | -1,273 | - | -401.93 | -220.4 |
Other Unusual Items | - | - | -1,463 | - | - | - |
Pretax Income | -324.98 | 884.64 | -8,060 | -3,832 | 6,128 | -4,966 |
Income Tax Expense | 26.81 | 239.02 | -1,760 | -387.14 | 882.84 | -516.73 |
Net Income | -351.79 | 645.61 | -6,300 | -3,445 | 5,245 | -4,449 |
Net Income to Common | -351.79 | 645.61 | -6,300 | -3,445 | 5,245 | -4,449 |
Shares Outstanding (Basic) | 11 | 11 | 11 | 11 | 11 | 8 |
Shares Outstanding (Diluted) | 11 | 11 | 11 | 11 | 11 | 8 |
Shares Change (YoY) | 0.60% | 0.05% | -0.04% | -3.41% | 36.03% | 167.50% |
EPS (Basic) | -32.35 | 59.41 | -580.00 | -317.00 | 492.55 | -538.00 |
EPS (Diluted) | -32.35 | 59.41 | -580.00 | -317.00 | 344.00 | -538.00 |
Free Cash Flow | -21.91 | -3,763 | 10,766 | -8,679 | -5,205 | 3,487 |
Free Cash Flow Per Share | -2.02 | -346.30 | 991.10 | -798.65 | -462.61 | 421.64 |
Gross Margin | 29.44% | 32.46% | 20.73% | 18.52% | 32.13% | 41.47% |
Operating Margin | -1.78% | 3.86% | -9.86% | -13.95% | 3.35% | 11.85% |
Profit Margin | -1.12% | 1.81% | -18.52% | -10.06% | 15.67% | -12.87% |
Free Cash Flow Margin | -0.07% | -10.55% | 31.64% | -25.35% | -15.55% | 10.09% |
EBITDA | 598.74 | 3,157 | -746.91 | -2,538 | 3,411 | 6,272 |
EBITDA Margin | 1.90% | 8.86% | -2.20% | -7.41% | 10.19% | 18.15% |
D&A For EBITDA | 1,158 | 1,779 | 2,607 | 2,239 | 2,289 | 2,177 |
EBIT | -559.16 | 1,378 | -3,354 | -4,777 | 1,122 | 4,096 |
EBIT Margin | -1.78% | 3.86% | -9.86% | -13.95% | 3.35% | 11.85% |
Effective Tax Rate | - | 27.02% | - | - | 14.41% | - |
Advertising Expenses | - | 59.38 | 268.31 | 271.48 | 197.66 | 83.57 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.